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Purpose: Rapid development of nanotechnology has recently brought significant attention to the 
extraordinary biological features of nanomaterials. The objective of the present   investigation was 
to evaluate morphological characteristics of the assembles of gold and platinum nanoparticles 
(nano-Au and nano-Pt respectively), with Salmonella Enteritidis (Gram-negative) and Listeria 
monocytogenes (Gram-positive), to reveal possibilities of constructing bacteria-nanoparticle 
vehicles.
Methods: Hydrocolloids of nano-Au or nano-Pt were added to two bacteria suspensions in 
the following order: nano-Au + Salmonella Enteritidis; nano-Au + Listeria monocytogenes; 
nano-Pt + Salmonella Enteritidis; nano-Pt + Listeria monocytogenes. Samples were inspected 
by transmission electron microscope.
Results: Visualization of morphological interaction between nano-Au and Salmonella Enteritidis 
and Listeria monocytogenes, showed that nano-Au were aggregated within flagella or biofilm net-
work and did not penetrate the bacterial cell. The analysis of morphological effects of interaction 
of nano-Pt with bacteria revealed that nano-Pt entered cells of Listeria monocytogenes and were 
removed from the cells. In the case of Salmonella Enteritidis, nano-Pt were seen inside bacteria 
cells, probably bound to DNA and partly left bacterial cells. After washing and centrifugation, 
some of the nano-Pt-DNA complexes were observed within Salmonella Enteritidis.
Conclusion: The results indicate that the bacteria could be used as a vehicle to deliver nano-Pt 
to specific points in the body.
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Introduction
There is an urgent need for new, effective drug delivery systems. In the last few 
decades, nanotechnology has been increasingly employed in searching for methods 
to transport drugs to certain organs within the human body. Transporting systems 
able to transmit cell-insoluble drugs into cells; non-toxic for the surroundings; and 
with time-prolonged releasing of active substances, have remarkable potential for 
  improving cancer therapy efficacy.1
Several bacteria isolates may be applied for possible new drug delivery   mechanisms. 
Their unique features including: potential to move; intracellular survival; and ability to 
settle in precisely programmed points of the body, allow the use of bacteria as specific 
medicine carriers.2 However, the following has still to be elucidated: how can bacteria 
be enforced to ingest medicines; how can uncontrolled proliferation and distribution 
of bacteria be avoided within a host organism; and can nanoparticles be used as drugs, 
or links between drugs and bacteria?International Journal of Nanomedicine 2010:5
Figure  1  TeM  image  of  nanoparticles  manufactured  by  electric  non-explosive 
method: a) gold b) platinum.
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Nanoparticles derived from noble metals are recognized 
as being non-genotoxic for the organism.3 Moreover, gold 
and silver nanoparticles did not reveal proinflammatory 
  activity4 and even antiangiogenic properties of Au nano-
particles (nano-Au) were observed.5 Nano-Au have been 
identified as promising candidates for many biological and 
biomedical applications.6 They have been widely used as an 
inert agent for cell imaging, targeted drug delivery, cancer 
diagnostics, and various therapeutic applications, due to 
their small sizes, convenience in bioconjugation, and strong 
absorbing and scattering properties.7–10 They entrap small 
drugs, or biopharmaceutical agents such as therapeutic 
  proteins and DNA, and can be designed to release these 
agents at the target site.
Platinum nanoparticles (nano-Pt) are of great interest 
due to their exceptional catalytic activity, which is affected 
by the ligands at their external surface. Nano-Pt may display 
multiple functional groups at the surface, which can be hydro-
philic, lipophilic, and chemically reactive.11 Some of the Pt 
compounds are used as very effective anticancer agents. This 
property is associated with the inhibition of DNA replication 
and mitosis by the addition of nano-Pt to DNA strand.12 On 
the other side, research of Hikosaka et al13 has revealed that 
nano-Pt have a nicotinamide adenine dinucleotide (NADH): 
ubiquinone oxidoreductase-like activity. This finding suggests 
that nano-Pt can be used as a remedy for   oxidative stress 
diseases with suppressed mitochondrial   complex I.13 Affinity 
of nano-Pt to DNA strand can also support their activity as 
carriers locating medicine within bacteria.
Salmonella Enteritidis is a motile, gram-negative (G-), rod-
shaped bacterium belonging to the Enterobacteriaceae family. 
It is adapted to a wide range of hosts. Through flagella, this 
bacterium can spread from the intestine to the blood and lymph. 
It proliferates within eukaryotic cells. Recent work has shown 
that Salmonella Enteritidis reside within macrophages.14
Listeria monocytogenes is a gram-positive (G+), food-
borne pathogenic bacterium, which possesses the ability to 
be internalized by macrophages and non-phagocytic cells, 
including epithelial cells, endothelial cells, and hepatocytes. 
It enters the cell using advanced mechanisms, proliferates 
intracellularly and spreads without contact with the extracel-
lular medium, using elongated protrusions.15
Methods to deliver functional nano-molecules to specific 
targets within the body still remain to be investigated. In addi-
tion, the impact of noble metals’ nanoparticles on   bacteria’s cells 
is still unclear. Considering physical and   chemical properties of 
gold (Au) and platinum (Pt)   nanoparticles and biological prop-
erties of Salmonella   Enteritidis and Listeria monocytogenes, 
it is important to evaluate results of their self-organization. 
Consequently, the objective of the present investigation was 
to evaluate morphological   characteristics of the assembles of 
nano-Au and nano-Pt with G+ and G- bacteria, to reveal pos-
sibilities of constructing   bacteria-nanoparticle vehicles.
Methods
Nanoparticles
Hydrocolloids of nano-Au and nano-Pt were obtained from 
Nano-Tech Polska (Warsaw, Poland). They were produced 
by a patented electric non-explosive method (Polish patent 
380649) from high purity metals (99.9999%) and high purity 
demineralized water. Both hydrocolloids had a concentration 
of 50 ppm. Shape and size of nanoparticles were inspected 
using a JEM-1220 transmission electron microscope (TEM) 
at 80 KeV (JEOL, Tokyo, Japan), with a Morada 11 mega-
pixel camera (Olympus Soft Imaging Solutions GmbH, 
Münster, Germany) (Figure 1). Diameter of particles ranged 
from 2–29 nm for Au and from 2–19 nm for Pt. Samples 
of Au and Pt for TEM were prepared by placing droplets 
of hydrocolloids on to formvar-coated copper grids (Agar 
  Scientific Ltd., Stansted, UK). Immediately after drying of 
the droplets in dry air, grids were inserted into the TEM.
Bacteria
Bacteria strains (Salmonella enterica subspecies enterica 
serovar Enteritidis ATCC® 13076™ and Listeria monocy-
togenes ATCC 19111) were obtained from LGC Standards 
(Lomianki, Poland). Salmonella Enteritidis were grown on 
nutritive 2.8% agar (Bio-Rad, Hercules, CA, USA). List-
eria monocytogenes were grown on brain heart infusion 
agar (Bio-Rad, Hercules, CA, USA) for 24 hours at 37°C. 
Bacteria were gently washed out from the agar using sterile 
distilled water. To remove liquid remains of the medium, bac-
teria were centrifuged at 4000 rpm for 5 min on an Eppendorf 
MiniSpin® centrifuge (Eppendorf, Hamburg, Germany) and 
the sediment (pellet) was re-suspended in Milli-Q water 
  (Millipore, Billerica, MA, USA). To calculate the exact 
  number of bacteria in the suspension, the optical density at International Journal of Nanomedicine 2010:5
Figure  2  TeM  image  of  Salmonella  enteritidis  and  gold  (Au)  nanoparticles:   
a) control; b, c, and d) Salmonella enteritidis with Au nanoparticles. Arrows point 
to nano-Au.
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600 nm (OD600) was estimated using a spectrophotometer 
Helios Epsilon unicam (USA) and serial dilutions of the 
suspension were prepared. One milliliter of each dilution was 
transferred to petri dishes with agar. After 24 hours incuba-
tion at 37oC, the number of colonies was estimated. Based 
on the results of measurements carried out in triplicate, the 
density of bacteria suspension OD600 = 0.130 corresponded 
to 2.2 × 108 cfu.mL-1; and OD600 = 0.133 corresponded to 
4 × 108 cfu.mL-1, for Salmonella Enteritidis and Listeria 
monocytogenes respectively.
Preparation of samples and microscopy
experiment 1
Hydrocolloids of nano-Au or nano-Pt (200 µL) were added 
to two bacteria suspensions (200 µL) in the following order: 
nano-Au + Salmonella Enteritidis; nano-Au + Listeria 
monocytogenes; nano-Pt + Salmonella Enteritidis; nano-Pt + 
Listeria monocytogenes. Control samples of bacteria were 
treated with Milli-Q water. The samples were gently mixed 
for 15 min and then droplets of the samples were put on 
formvar-coated 300 mesh copper grids (Agar Scientific Ltd., 
Stansted, UK). The samples were dried at room temperature, 
under sterile conditions, and inspected using a JEM-2000EX 
TEM (JEOL, Tokyo, Japan).
experiment 2
Hydrocolloids of nano-Pt (200 µL) were added to Salmo-
nella Enteritidis suspension (200 µL). To remove unattached 
nanoparticles, the samples were gently mixed for 15 min 
and then centrifuged at 4000 rpm for 5 min, washed with 
ultrapure Milli-Q water, centrifuged at 4000 rpm for 5 min, 
and re-suspended in Milli-Q water. Samples for microscopic 
evaluation were prepared using the methods described 
above. Control samples of bacteria not treated with nano-
particles were prepared using the same methods.
experiment 3
In the third experiment, we wanted to confirm that the sub-
stance realized from Salmonella Enteritidis, after nano-Pt 
treatment, was DNA. Furthermore, the viability of bacteria 
after incubation with nano-Pt was determined. Bacteria sus-
pended in phosphate buffering solution (PBS) were divided 
into the control sample, to which 0.5 mL of Milli-Q water 
was added, and four samples, to which 0.5 mL of colloidal 
nano-Pt was added. Samples were incubated for 45, 60, and 
90 min and then centrifuged at 5000 rpm for 5 min. The 
supernatant was discarded and the remaining pellet con-
taining bacteria was suspended in 0.5 mL solution with the 
fluorescent marker DAPI (4’,6-diamidyno-2-fenyloindol) and 
PBS in the proportion 1 µL DAPI to 1 mL PBS. Bacteria 
with the fluorescent dye were incubated for 15 min. After 
this time, to remove overdose of the dye, samples were cen-
trifuged (5000 rpm for 5 min) and the obtained pellet was 
suspended in 200 µL PBS. The control was a suspension 
of bacteria in 200 µL of PBS, subjected to all stages of 
the experiment, except the incubation with nano-Pt. The 
resulting suspension was thoroughly stirred and one drop 
was placed on a microscope slide and immediately covered 
with a coverslip. The resulting preparations were observed 
at 300x magnification with an Olympus FV1000 confocal 
microscope, with FV10-ASW software version 1.4 (Olympus 
Corporation, Tokyo, Japan). The preparations were observed 
at the excitation wave length of 405 nm and in the Nomarski 
contrast. The viability of Salmonella Enteritidis was also 
measured. Samples of Salmonella Enteritidis, prepared as in 
experiment 1, were incubated with hydrocolloids of nano-Pt 
(1:1) and with Milli-Q water as the control, for 45, 60, and 90 
min. Samples of Salmonella Enteritidis were then spread and 
grown on nutritive 2.8% agar (Bio-Rad, Hercules, CA, USA), 
for 24 hours, at 37°C and bacterial colonies were counted.
Results
experiment 1
Examination of the control bacteria indicated some changes 
caused by the used methods (centrifugation, Milli-Q water, 
drying), but did not show any toxicological or destructive 
alteration of bacteria. Morphology of interaction between 
nano-Au and Salmonella Enteritidis is presented in Figure 2. 
Almost all of nano-Au were aggregated and removed from 
bacterial cells. The aggregates were trapped within flagella 
network and biofilm. Moreover, some bacteria cells were International Journal of Nanomedicine 2010:5
Figure  3  TeM  image  of  Listeria  monocytogenes  and  gold  (Au)  nanoparticles:   
a) control; b, c, and d) Listeria monocytogenes with Au nanoparticles. Arrows point 
to nano-Au (b and d); and to aglomerate of nano-Au (c).
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destroyed and their cell walls were disrupted. The cells were 
malformed, had shrunk, and a loss of cytoplasm was observed. 
Interestingly, nano-Au was trapped within the flagella-biofilm 
network and kept at some distance from bacteria.
The results of the morphological interaction of gold nano-
particles with Listeria monocytogenes also showed that nano-Au 
were aggregated and non-specifically placed on the cell wall 
(Figure 3). The cell wall was disintegrated and the cytoplasmic 
membrane was disrupted. Thereafter, nano-Au were entirely 
surrounded by biofilm and removed from bacteria.
The visualization of the interaction between nano-Pt and 
Salmonella Enteritidis is shown in Figure 4. The picture shows 
that nano-Pt disintegrated bacteria cell walls and cytoplas-
matic membranes; moreover, they entered bacteria and were 
seen as intensively black spots within the cells. Nano-Pt were 
located specifically, probably attached to some intracellular 
compounds (DNA), but under microscope electron beam, 
these black spots evaporated becoming white (Figure 4c).
The image of interaction between nano-Pt and List-
eria monocytogenes, shown in Figure 5, indicated that 
nano-Pt are destructive to these bacteria. The influence 
of nano-Pt on Listeria monocytogenes clearly pointed out 
that nano-Pt were seen within bacteria, moreover, they were 
located close to DNA and probably bound to it. Interestingly, 
these new molecules (nano-Pt with DNA) were removed or 
escaped from the bacteria cells. The cell wall and cytoplas-
matic membrane were disintegrated and cytoplasm was lost. 
As in the case of Salmonella Enteritidis, nano-Pt evaporated 
under the electron beam.
experiment 2
This experiment was performed to elucidate to what extent 
nanoparticles, identified from morphological pictures in 
experiment one, as attached or being inside bacteria, were 
truly attached or were stably anchored bacteria cells. To 
remove unattached particles, mixtures with bacteria were 
centrifuged and washed. For further examination, Salmonella 
Enteritidis was chosen as a better candidate for bacteria-
nanoparticle molecules construction. It was revealed that 
platinum complexes seen as intensively black spots were still 
within the bacteria (Figure 6).
experiment 3
This experiment was performed to confirm that nano-Pt is 
actually removing DNA from Salmonella Enteritidis, and 
whether this process is time-dependent. In this experiment, 
the average number of bacteria observed by the confocal 
microscope in the Nomarski contrast and the average number 
of bacteria labelled with DAPI (DNA-binding fluorochrome) 
were determined. The average number of bacteria cells 
(Table 1) seen as a cell wall image observed with the Nomar-
Figure  4  TeM  image  of  Salmonella  enteritidis  and  platinum  (Pt)  nanoparticles:   
a) control; b, c, and d) the same cell of Salmonella enteritidis with Pt nanoparticles. 
Arrows point to nano-Pt (b); and the spots observed with increasing magnification 
(b, c, and d). Black spots are seen evaporating under the microscope electron beam 
and are finally seen as white spots.
Figure  5  TeM  image  of  Listeria  monocytogenes  and  platinum  (Pt)  nanoparticles:   
a) control; b, c, and d) Listeria monocytogenes with nano-Pt. Arrows point to nano-PT 
(b and c); and to black spot partially evaporated under microscope electron beam (b).International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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ski contrast (Figure 7), after incubation for 45, 60, and 90 min 
with nano-Pt, did not change. However, the number of cells 
containing DNA (seen as a blue) was reduced after 60 and 
90 min. Viability of Salmonella Enteritidis was also decreased 
and after 60 and 90 min of incubation, was about one quarter 
of that measured in the control condition (Table 1).
Discussion
The purpose of the present study was to identify possibilities 
of using bacteria as a vehicle for transporting nanoparticles 
and/or nanoparticle-drug molecules. We focused on 
possibilities of placing nanoparticles of Au and Pt within 
bacteria, using a simple mechanism of self-organization, but 
without destroying cell walls of bacteria. The biological action 
of nanoparticles on mammalian and bacterial cells is highly 
dependent on their functional groups present on the surface 
of nanoparticles, which may determine their toxicity.16,17 
To avoid influence of the additional   chemical groups which 
surround nanoparticles and to determine chemical properties 
of nanoparticles, we used nano-Au and nano-Pt produced in 
high purity water by electric methods (the same for Au and 
Pt). Consequently, only hydrogen ion (H+) or hydroxide ion 
(OH-) groups could be present on the nanoparticle surface.
The structure of the cell wall of G+ Listeria monocy-
togenes and G- Salmonella Enteritidis is quite different. 
Listeria monocytogenes has a thick (20–80 nm), continu-
ous cell wall composed of highly cross-linked layers of 
  peptidoglycan, covalently bound to teichoic acids, while the 
Salmonella Enteritidis cell wall is thin (5–10 nm) but more 
complex.   Peptidoglycan is surrounded by an outer membrane 
containing lipolysaccharide and also by some non-specific 
porins, which can potentially transport smaller nanoparticles 
(around 1 nm). Interestingly, in spite of significant differences 
in cell walls structure, the self-organization between nano-
particles and bacteria was affected by the type of bacteria to 
a lesser degree than by the type of nanoparticles.
In our studies, nano-Au formed aggregates trapped 
within flagella network, when examined with Salmonella 
Enteritidis (Figure 2). The pictures might indicate that this 
process is initiated by fimbria network creation, which 
probably promotes the development of biofilm.18 Forma-
tions of biofilm by Salmonella Enteritidis increase coloni-
zation, but also protect bacteria cells,19 which in this case 
could be a system of protection against nanoparticles. The 
formation of nano-Au aggregates kept the nanoparticles 
away from the bacteria cells, which might be more safe 
for the bacteria but unsuitable for constructing a bacteria-
nanoparticle drug delivery system. Listeria monocytogenes 
also produced biofilm, but mainly showed abilities to form 
colonies, making it impossible to observe single cells as 
it was in the case of Salmonella Enteritidis (Figure 3). 
Probably, building a multi-cells structure was, for Listeria 
monocytogenes, a form of protection against nano-Au, but 
make it difficult to use Listeria monocytogenes as a drug 
delivery vehicle.
Nanoparticles of Au were mainly placed outside bacteria 
(Figure 2 and 3), however, some aggregates, containing small 
Figure  6  TeM  image  of  Salmonella  enteritidis  and  platinum  (Pt)  nanoparticles, 
after washing and centrifugation to remove nanoparticles unattached to bacteria:   
a) control; b, c, and d) Salmonella enteritidis with nano-Pt. Arrows point to nano-Pt 
complexes.
Table 1 Average number and viability of Salmonella enteritidis incubated with nano-Pt for 45, 60, and 90 min. DNA visualization was 
performed by labelling bacteria with DAPI (DNA-binding fluorochrome) 
Incubation with nano-Pt (min) ANOVA
Control 45 60 90 SEM P-value
Number of bacteria 56.3 47.0 46.7 59.4 6.34 NS
Number of bacteria stained  
with DAPI 
35.3a 35.0a 14.7b 22.3b 4.57 0.000
Percentage of bacteria stained  
with DAPI
62.6a 74.5a 31.9b 37.5b 0.04 0.000
Viability, cFU/mL 28.5 × 105 31.2 × 105 10.3 × 105 7.1 × 105
Notes: Values in each row with different superscript letters (a or b) differ significantly (P , 0.05).
Abbreviations: NS, not significant (P . 0.05); SeM, standard error of the mean.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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(about 5–10 nm) particles of nano-Au, were non-specifically 
placed on the surface of both bacteria. Bacterial cell walls and 
cytoplasm membrane in both bacteria were disintegrated, but 
nano-Au were not seen inside the cells. Pan et al20 observed that 
particles of 1–2 nm were highly toxic and that nanoparticles 
larger than 15 nm were not toxic. Consequently, the possibility 
that the smallest (about 1 nm) nanoparticles could enter the 
cells could be considered. However, in the present experiment, 
it was not possible to observe such small nanoparticles.
In the present experiment, the visualization of the asso-
ciation between nano-Pt and bacteria indicated significant 
effects of nano-Pt on both Salmonella Enteritidis and 
Listeria monocytogenes. Cell wall and cytoplasmic mem-
brane of both bacteria were disintegrated, however, Listeria 
monocytogenes, like in the case of nano-Au, created colo-
nies, probably as a defence against nano-Pt. Interestingly, 
  Salmonella Enteritidis did not demonstrate the mechanism 
of fimbria-biofilm production, which was seen as a remedy 
against nano-Au. Moreover, we noticed that the cell wall 
and cytoplasmic membrane of both microorganisms were 
permeable for nano-Pt, which could be seen as intensively 
black spots, being black even when microscopic pictures 
were lightened and not existing in the control bacteria. 
Moreover, the present pictures (Figure 4, 5) showed that 
nano-Pt was bound to specific intracellular compounds; 
probably DNA. Our results are in agreement with previous 
studies,21 revealing that platinum demonstrates effective 
affinity to DNA strand. These properties may be utilized 
for using nano-Pt conjugates to inhibit DNA replication, 
by binding to its strand and therefore acting as potential 
anticancer agents. The antioxidant activity of platinum 
complexes, which can penetrate the nucleus membrane 
and enter the nucleus, has recently gained attention due 
to its potential for the treatment of a variety of cancers.22 
For example, cisplatin and carboplatin are used as che-
motherapeutic agents for ovarian and testicular cancer.23 
It is well known that in cancer therapy, tissue-unspecific 
drug application is a key problem. The possibility to locate 
nano-Pt inside bacteria ghost, being a locomotive force, 
could provide target-specific drug delivery. Previously, 
bacterial cells as ghosts were used as a very promising drug 
delivery system in a study with Escherichia coli.2
In the case of Listeria monocytogenes, we observed that 
nano-Pt-DNA molecules (as intensively black spots) were seen 
inside the cells, but the majority was placed outside the cells. 
It is therefore likely that nano-Pt, after binding with DNA, was 
removed from Listeria monocytogenes (Figure 5). In the case of 
Salmonella Enteritidis, the association of nano-Pt and DNA was 
also visualized as dark spots (Figure 4), but seen rather within 
bacteria cells. Interestingly, these spots were disappearing under 
the microscope electron beam, especially when magnification 
was increasing. In   Salmonella Enteritidis, in contrast to Listeria 
monocytogenes, the spots were mostly inside the bacterial cells 
and only a few were removed from bacteria cells.
Considering the results from the first experiment, only 
Salmonella Enteritidis and nano-Pt were chosen in the second 
experiment, because only nano-Pt was undoubtedly seen within 
Salmonella Enteritidis, and did not flow out from the cells. 
In this experiment, Salmonella Enteritidis were mixed with 
nano-Pt and then centrifuged and washed to remove nano-
particles being unbound or unattached to bacteria’s structures. 
As we supposed, dark spots placed within bacteria could be 
observed (Figure 6). However, only a part of bacterial cells still 
had the spots while the other bacterial bodies were empty.
In experiment 3, we confirmed our hypothesis that after 
treatment with nano-Pt, DNA is removed from cells of 
  Salmonella Enteritidis. However, after 60 min of incuba-
tion, only about half of the cells lost their DNA, moreover, 
this process did not increase in the following 30 min. Abili-
ties of nano-Pt entering Salmonella cells and binding with 
DNA seem to be very promising for a drug delivery system, 
1
2
3
4
Figure 7 confocal microscope image of Salmonella enteritidis: 1) control; 2, 3, and 4) 
after incubation with platinum nanoparticles for 45, 60, and 90 min respectively.   
a) Nomarski contrast; b) stained with DAPI; and c) merged pictures.International Journal of Nanomedicine
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even when only part of bacterial cells contain nano-Pt-DNA 
molecules. A fundamental problem seems to be determination 
of optimal time and other conditions of incubation allowing 
location of nano-Pt within bacteria and binding with DNA. 
We have also examined viability of Salmonella Enteritidis 
after nano-Pt treatment, showing that after 90 min of incu-
bation, about 25% of bacteria was still able to replicate. It 
can be suspected that if about half of bacteria after incuba-
tion for 60–90 min with nano-Pt still contained DNA, and 
about a quarter of bacteria was still alive, the other quarter 
of bacteria contains nano-Pt-DNA molecule, but it is not 
able to replicate.
Conclusion
Visualization of morphological interaction between nano-
Au and Salmonella Enteritidis and Listeria monocytogenes, 
showed that nano-Au were aggregated within flagella or 
biofilm network, but were not specifically attached. In addi-
tion, nano-Au visible under the microscope did not penetrate 
inside the bacterial cell. The analysis of morphological 
effects of interaction between nano-Pt and bacteria revealed 
that nano-Pt entered cells of Listeria monocytogenes but 
were removed from the cells. In the case of Salmonella 
Enteritidis, nano-Pt were seen inside bacteria cells, indi-
cating that the bacteria cells could be used as a vehicle to 
deliver nano-Pt, and active substances attached to Pt, to 
specific points in the body.
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